New Distribution Deals for 3D Diagnostic Imaging
Scottish dental firm 3D Diagnostic Imaging has signed new distribution deals for its leading product, CarieScan.
The device, which identifies early signs of decay, is already sold in several countries around the world and the firm is now celebrating sealing new distribution deals, which will see the device sold to dental practices in the Middle East, Turkey and North Africa.
News of the new deals caused share prices to increase after a period of uncertainty, which saw the price fall to 0.45 pence.
The directors of 3D Diagnostic Imaging admitted that the last few months had been difficult following a very positive start to life in the trading markets in 2010. Shares reached a record high of 9 pence, before gradually decreasing over the course of the last six months to reach a record low of 0.45 pence last week.
Graham Lay, the firm’s chief executive, said that that everyone was delighted with the new distribution deals and pleased that sales are picking up. Recent monthly figures have made for much better reading and the firm is confident that the share price and sales will continue to rise, especially with new deals now in place to expand exports.
CarieScan is already distributed in 13 countries and three distributors have made re-orders. The most recent distribution deals will give the firm access to around 172,000 dentists in Turkey, North Africa and the Middle East.
Join this Discussion
